Kembali
KLBF - Kalbe Farma

KLBF – No significant impact from Trump’s policy

14 Agustus 2025

KLBF – No significant impact from Trump’s policy Kalbe Farma (KLBF) has not experienced any significant impact from global trade tensions caused by Trump’s tariff policy on certain export products. Currently, KLBF has no sales exposure to the US, focusing instead on markets in ASEAN, Africa, and Asia. Note that, KLBF posted revenue of IDR17.07 tn (+4.5% yoy) and net profit of IDR2.02 tn (+10.77% yoy) in 1H25. For this year, KLBF targets revenue and net profit growth of around 6–8% yoy. (Source : Kontan)

Related Research

Consumer
KLBF - Performa solid pada kuartal pertama tahun 2022
Winny Rahardja 10 Mei 2022 Lihat Detail
Consumer
KLBF - Expects a Brighter 24F, after a weak 23f
Andre Suntono 20 Maret 2024 Lihat Detail
Healthcare
KLBF - Further growth in ‘25F on better product mix and costs ma...
Andre Suntono 13 Juni 2025 Lihat Detail